Published: Mar 5, 2021 | Tags: Eli Lilly and Incyte, Report, Results, Olumiant (baricitinib), P-III, BRAVE-AA2, Study, Severe, Alopecia Areata
Takeda Reports NDA Submission to Import and Distribute Moderna’s mRNA-1273 in Japan
Published: Mar 5, 2021 | Tags: Takeda, Reports, NDA, Submission, Import, Distribute, Moderna, mRNA-1273, Japan
Published: Mar 5, 2021 | Tags: Roche, Actemra/RoActemra (tocilizumab), Receives, US, FDA, Approval, First, Biologic, Systemic Sclerosis-Associated Interstitial Lung Disease
Agilent to Acquire Resolution Bioscience for $695M
Published: Mar 5, 2021 | Tags: Agilent, Acquire, Resolution Bioscience, $695M
Lilly Reports Results of Tirzepatide in P-lll SURPASS-2 Trial for Type-2 Diabetes
Published: Mar 5, 2021 | Tags: Lilly, Reports, Results, Tirzepatide, P-lll, SURPASS-2, Trial, Type-2 Diabetes
Amgen to Acquire Five Prime for ~$1.9B
Published: Mar 5, 2021 | Tags: Amgen, Acquire, Five Prime, ~$1.9B
Vir and GSK Provide Update on ACTIV-3 Trial of VIR-7831 in Hospitalized Adults with COVID-19
Published: Mar 4, 2021 | Tags: Vir and GSK, Provide, Update, ACTIV-3, Trial, VIR-7831, Hospitalized Adults, COVID-19
Published: Mar 4, 2021 | Tags: Roche, Collaborates, Tempest, Evaluate, TPST-1120, Combination, Study, 1L, Treatment, Hepatocellular Carcinoma
Published: Mar 4, 2021 | Tags: Regeneron and Sanofi, Report, US, FDA, Acceptance, sBLA, Review, Dupixent, Treat, Moderate-to-Severe, Asthma, Children
Published: Mar 4, 2021 | Tags: Pfizer, Lorbrena (lorlatinib), Receives, FDA, Approval, Expanding, Indication, Treat, ALK-Positive Metastatic, Lung Cancer
Published: Mar 4, 2021 | Tags: Takeda, Signs, Exclusive, License, Agreement, Ovid, Soticlestat, Treat Dravet Syndrome, Lennox-Gastaut Syndrome
Boston Scientific Signs an Agreement with BPEA to Acquire Lumenis’ Surgical Business
Published: Mar 4, 2021 | Tags: Boston Scientific, Signs, Agreement, BPEA, Acquire, Lumenis, Surgical Business
Published: Mar 3, 2021 | Tags: Amgen, Reports, Results, Blincyto (blinatumomab), P-III, Study, Relapsed Acute Lymphoblastic Leukemia, Pediatric, Patients
Published: Mar 3, 2021 | Tags: BeiGene, Brukinsa (zanubrutinib), Receives, Health Canada, Approval, Waldenström’s Macroglobulinemia
Fusion to Acquire Ipsen’s IPN-1087 to Expand its Pipeline of Radiopharmaceuticals
Published: Mar 3, 2021 | Tags: Fusion, Acquire, Ipsen, IPN-1087, Expand, Pipeline, Radiopharmaceuticals
G1 Therapeutics and Boehringer Ingelheim Launch Cosela (trilaciclib) in the US
Published: Mar 3, 2021 | Tags: G1 Therapeutics and Boehringer Ingelheim, Launch, Cosela (trilaciclib), US
Biocon Biologics and Viatris Receive CHMP’s Positive Opinion for Abevmy (biosimilar, bevacizumab)
Published: Mar 3, 2021 | Tags: Biocon Biologics and Viatris, Receive, CHMP, Positive Opinion, Abevmy (biosimilar, bevacizumab)
AbbVie Signs a Purchase Right Agreement to Acquire Mitokinin
Published: Mar 3, 2021 | Tags: AbbVie, Signs, Purchase, Right, Agreement, Acquire, Mitokinin
Published: Mar 2, 2021 | Tags: Veru, Advance, VERU-111, P-III, Study, COVID-19, Patients, High Risk, Acute Respiratory Distress Syndrome
AstraZeneca Collaborates with Junshi to Commercialize Toripalimab in China
Published: Mar 2, 2021 | Tags: AstraZeneca, Collaborates, Junshi, Commercialize, Toripalimab, China
Hologic to Acquire Diagenode for ~$159M
Published: Mar 2, 2021 | Tags: Hologic, Acquire, Diagenode, ~$159M
Samsung Bioepis Initiates P-I Study of SB17 Proposed Biosimilar to Stelara (ustekinumab)
Published: Mar 2, 2021 | Tags: Samsung Bioepis, Initiates, P-I, Study, SB17, Proposed, Biosimilar, Stelara (ustekinumab)
Published: Mar 2, 2021 | Tags: Merck, Reports, US, FDA, Acceptance, NDA, Review, Gefapixant, Treat, Unexplained, Chronic Cough
Merck KGaA Sign an Exclusive Worldwide License Agreement with Debiopharm for Xevinapant
Published: Mar 2, 2021 | Tags: Merck KGaA, Sign, Exclusive, Worldwide, License, Agreement, Debiopharm, Xevinapant
Published: Mar 1, 2021 | Tags: BMS, Opdivo (nivolumab), Cabometyx (cabozantinib), Receive, CHMP, Positive Opinion, 1L, Treatment, Advanced Renal Cell Carcinoma
Published: Mar 1, 2021 | Tags: Regeneron, Ab Cocktail (casirivimab + imdevimab), Receives, CHMP, Positive, Opinion, Treat, COVID-19
Johnson & Johnson Receives the US FDA’s EUA for COVID-19 Vaccine
Published: Mar 1, 2021 | Tags: Johnson & Johnson, Receives, US, FDA, EUA, COVID-19, Vaccine
AstraZeneca and Amgen Report Results of Tezepelumab in P-III NAVIGATOR Trial for Severe Asthma
Published: Mar 1, 2021 | Tags: AstraZeneca and Amgen, Report, Results, Tezepelumab, P-III, NAVIGATOR, Trial, Severe Asthma
Roivant to Acquire Silicon Therapeutics for ~$450M
Published: Mar 1, 2021 | Tags: Roivant, Acquire, Silicon Therapeutics, ~$450M
Published: Mar 1, 2021 | Tags: BridgeBio and Origin, Nulibry (fosdenopterin), Receives, US, FDA, Approval, First, Therapy, Reduce, Risk, Mortality, Patients, MoCD Type A
Related Post: PharmaShots Weekly Snapshots (Feb 22- 26, 2021)
The post PharmaShots Weekly Snapshots (Mar 01 – 05, 2021) first appeared on PharmaShots.